Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kostas Pantopoulos

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 25, 2018
Hepcidin TherapeuticsAngeliki Katsarou, Kostas Pantopoulos
IUBMB Life|April 8, 2017
Systemic iron homeostasis and erythropoiesisGeorge Papanikolaou, Kostas Pantopoulos
Advances in Experimental Medicine and Biology|July 2, 2025
Oral and Intravenous Iron TherapyAndrea U Steinbicker, Kostas Pantopoulos
Journal of Visualized Experiments : Jove|December 31, 2014
Electrophoretic mobility shift assay (EMSA) for the study of RNA-protein interactions: the IRE/IRP exampleCarine Fillebeen, Nicole Wilkinson, Kostas Pantopoulos
Frontiers in Pharmacology|July 23, 2016
Pharmacological Targeting of the Hepcidin/Ferroportin AxisGiada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos
FEBS Letters|February 2, 2011
Redox control of iron regulatory protein 2 stabilityAnja Hausmann, Julie Lee, Kostas Pantopoulos
Biochimica Et Biophysica Acta|November 17, 2011
Regulation of iron transport and the role of transferrinKonstantinos Gkouvatsos, George Papanikolaou, Kostas Pantopoulos
Plos One|July 12, 2019
Hepatocellular heme oxygenase 1 deficiency does not affect inflammatory hepcidin regulation in miceEdouard Charlebois, Carine Fillebeen, Kostas Pantopoulos
The Biochemical Journal|August 12, 2005
Inhibition of transferrin receptor 1 transcription by a cell density response elementJian Wang, Guohua Chen, Kostas Pantopoulos
The Biochemical Journal|December 5, 2002
The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulinJian Wang, Guohua Chen, Kostas Pantopoulos
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Pharmaceuticals (Basel, Switzerland)|November 25, 2018
Hepcidin TherapeuticsAngeliki Katsarou, Kostas Pantopoulos
IUBMB Life|April 8, 2017
Systemic iron homeostasis and erythropoiesisGeorge Papanikolaou, Kostas Pantopoulos
Advances in Experimental Medicine and Biology|July 2, 2025
Oral and Intravenous Iron TherapyAndrea U Steinbicker, Kostas Pantopoulos
Journal of Visualized Experiments : Jove|December 31, 2014
Electrophoretic mobility shift assay (EMSA) for the study of RNA-protein interactions: the IRE/IRP exampleCarine Fillebeen, Nicole Wilkinson, Kostas Pantopoulos
Frontiers in Pharmacology|July 23, 2016
Pharmacological Targeting of the Hepcidin/Ferroportin AxisGiada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos
FEBS Letters|February 2, 2011
Redox control of iron regulatory protein 2 stabilityAnja Hausmann, Julie Lee, Kostas Pantopoulos
Biochimica Et Biophysica Acta|November 17, 2011
Regulation of iron transport and the role of transferrinKonstantinos Gkouvatsos, George Papanikolaou, Kostas Pantopoulos
Plos One|July 12, 2019
Hepatocellular heme oxygenase 1 deficiency does not affect inflammatory hepcidin regulation in miceEdouard Charlebois, Carine Fillebeen, Kostas Pantopoulos
The Biochemical Journal|August 12, 2005
Inhibition of transferrin receptor 1 transcription by a cell density response elementJian Wang, Guohua Chen, Kostas Pantopoulos
The Biochemical Journal|December 5, 2002
The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulinJian Wang, Guohua Chen, Kostas Pantopoulos
Pageof 12